BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2276680)

  • 1. Erythropoietin: biological aspects and clinical usefulness.
    Liberato NL; Costa A; Barosi G
    Haematologica; 1990; 75(4):346-62. PubMed ID: 2276680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin. Experimental and clinical applications.
    Nielsen OJ
    Dan Med Bull; 1991 Oct; 38(5):355-70. PubMed ID: 1802621
    [No Abstract]   [Full Text] [Related]  

  • 3. [Erythropoietin: its biological properties and clinical use].
    Ermolenko VM; Nikolaev AIu
    Ter Arkh; 1990; 62(11):141-5. PubMed ID: 2094979
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythropoietin: from molecular biology to clinical use.
    Lacombe C
    Eur Cytokine Netw; 1997 Sep; 8(3):308-10. PubMed ID: 9346370
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of chronic renal failure on the expression of erythropoietin message in a murine model.
    Zhang F; Laneuville P; Gagnon RF; Morin B; Brox AG
    Exp Hematol; 1996 Nov; 24(13):1469-74. PubMed ID: 8950229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Erythropoietin: from gene to therapeutic agent].
    Bauer C
    Schweiz Rundsch Med Prax; 1994 Jun; 83(23):698-701. PubMed ID: 8016510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological characterization of recombinant human erythropoietin.
    Krumwieh D; Arnold I; Seiler FR
    Behring Inst Mitt; 1988 Aug; (83):193-201. PubMed ID: 3240225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Erythropoietin in 1991--pathophysiological and therapeutic aspects].
    Wiecek A
    Przegl Lek; 1992; 49(1-2):31-5. PubMed ID: 1455002
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
    Arenas Gracia M; Abad Gosálvez A; Colomina Avilés J; Pascual Pérez R; Ferriz Moreno P
    An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin: biology and clinical use.
    Graber SE; Krantz SB
    Hematol Oncol Clin North Am; 1989 Sep; 3(3):369-400. PubMed ID: 2561121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure.
    Erslev AJ; Besarab A
    Kidney Int; 1997 Mar; 51(3):622-30. PubMed ID: 9067892
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythropoietin.
    Erslev AJ
    Leuk Res; 1990; 14(8):683-8. PubMed ID: 2201820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of erythropoietin.
    Urabe A; Kitamura T; Takaku F
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1355-9. PubMed ID: 3073611
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythropoietin: its role in the regulation of erythropoiesis and as a therapeutic in humans.
    Adamson JW
    Biotechnology; 1991; 19():351-63. PubMed ID: 1786475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological similarity of erythropoietin: controlled maturation].
    Combe C
    Nephrol Ther; 2009 Feb; 5 Spec No1():1-2. PubMed ID: 19233074
    [No Abstract]   [Full Text] [Related]  

  • 16. Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease.
    Bommer J; Kugel M; Schoeppe W; Brunkhorst R; Samtleben W; Bramsiepe P; Scigalla P
    Contrib Nephrol; 1988; 66():85-93. PubMed ID: 3292151
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythropoietin: in vitro and in vivo studies of the regulation of erythropoiesis.
    Adamson JW
    Schweiz Med Wochenschr; 1988 Oct; 118(42):1501-6. PubMed ID: 2849202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic kidney failure, anemia and erythropoietin].
    Sulková S
    Cas Lek Cesk; 1990 May; 129(18):545-9. PubMed ID: 2350772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease.
    Kühn K; Nonnast-Daniel B; Grützmacher P; Grüner J; Pfåffl W; Baldamus CA; Scigalla P
    Contrib Nephrol; 1988; 66():94-103. PubMed ID: 3292152
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of the anaemia of chronic renal failure with recombinant erythropoietin.
    Adamson JW; Eschbach JW
    Q J Med; 1989 Dec; 73(272):1093-101. PubMed ID: 2694210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.